Switch to:
More From Other Websites
Pharma Stock Roundup: Pfizer Files Suit against J&J, Supernus Hit by Study Update Sep 22 2017
Glaxo-Innoviva's Triple Combo Inhaler Positive in Phase III Sep 21 2017
How GlaxoSmithKline (GSK) Stock Stands Out in a Strong Industry Sep 21 2017
Is GlaxoSmithKline plc (GSK) a Suitable Value Stock? Sep 20 2017
GSK's new triple lung drug beats other modern inhalers in study Sep 20 2017
GSK and Innoviva Report Positive Headline Results from IMPACT Study Showing Single Inhaler Triple... Sep 20 2017
GlaxoSmithKline Plc – Value Analysis (US OTC:GLAXF) : September 20, 2017 Sep 19 2017
FDA OKs Glaxo's inhaler, first one to combine 3 medicines Sep 19 2017
Glaxo/Innoviva's Triple Combo Therapy Gets FDA Nod for COPD Sep 19 2017
[$$] Andrew Witty jumps into biotech venture capital Sep 19 2017
GlaxoSmithKline breathes easier as U.S. approves triple lung drug Sep 19 2017
Trelegy Ellipta approved as the first once-daily single inhaler triple therapy for the treatment of... Sep 18 2017
U.S. FDA approves GSK's three-in-one drug inhaler for COPD Sep 18 2017
Trelegy Ellipta Approved as the First Once-Daily Single Inhaler Triple Therapy for the Treatment of... Sep 18 2017
GlaxoSmithKline Plc breached its 50 day moving average in a Bearish Manner : GLAXF-US : September... Sep 18 2017
3 High-Yield Healthcare Stocks Sep 18 2017
Glaxo's Triple Therapy COPD Inhaler Gets CHMP Nod in the EU Sep 18 2017
France's Neovacs takes on GSK and AstraZeneca in battle to treat lupus Sep 15 2017
Pharma Stock Roundup: Achillion Slumps on End of HCV Deal, Teva Gets a New CEO Sep 15 2017
GSK's three-in-one inhaler gets positive opinion from EU agency Sep 15 2017


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK